Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Los Angeles, California--(Newsfile Corp. - August 13, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
Los Angeles, California--(Newsfile Corp. - August 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
CORRECTING and REPLACING Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
11:39am, Wednesday, 11'th Aug 2021
NEW YORK--(BUSINESS WIRE)-- #AXSM--Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
Los Angeles, California--(Newsfile Corp. - August 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Axsome Therapeutics, Inc. (“Axsome” or the �
Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
04:16pm, Tuesday, 10'th Aug 2021
NEW YORK--(BUSINESS WIRE)-- #AXSM--Scott+Scott Attorneys at Law LLP Announces Investigation into Axsome Therapeutics Inc. (AXSM)
Los Angeles, California--(Newsfile Corp. - August 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ax
LOS ANGELES--(BUSINESS WIRE)---- $AXSM #AXSM--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Axsome Therapeutics, Inc.
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Axsome Therapeutics, Inc. (NAS
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q2 2021 Results - Earnings Call Transcript
11:18am, Monday, 09'th Aug 2021
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q2 2021 Results - Earnings Call Transcript
Axsome Stock Drops To 52-Week Low On FDA Response Letter For Depression Candidate
11:02am, Monday, 09'th Aug 2021
Wrapped up in its Q2 earnings release, Axsome Therapeutics Inc (NASDAQ: AXSM) said that on July 30, it received an FDA letter for a marketing application for AXS-05 for the treatment of major depre
Axsome Therapeutics (AXSM) Sees Hammer Chart Pattern: Time to Buy?
09:19am, Monday, 09'th Aug 2021
Axsome Therapeutics (AXSM) has been struggling lately, but the selling pressure may be coming to an end soon.
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
07:05am, Monday, 09'th Aug 2021
Company to host conference call today at 8:00 AM Eastern
Is There Any Hope Left for Axsome Therapeutics?
06:21am, Friday, 30'th Jul 2021
After a fantastic run-up, investors are now losing faith in this emerging biotech's stock.
Will Axsome Stock Rebound After A 19% Fall In A Month?
08:00am, Friday, 23'rd Jul 2021
The stock price of Axsome Therapeutics, a biopharmaceutical company focused on developing novel therapies for central nervous system conditions, has seen a 19% drop over the last twenty-one trading da
